Ginkgo Bioworks Announces Q2 2026 Financial Results

What Happened

• On August 5, 2026, Ginkgo Bioworks Holdings, Inc. (DNA) announced its financial results for the quarter ended June 30, 2026 and filed a Current Report on Form 8-K (Item 2.02) to disclose the announcement. The company furnished the announcement as Exhibit 99.1 to the 8-K.
• The filing notes the company uses SEC filings, investor relations pages, press releases and social channels to release material information. The 8-K was signed by Chief Financial Officer Steven Coen.

Key Details

• Filing date: August 5, 2026 (Form 8-K, Item 2.02 and Item 9.01).
• Period covered: Quarter ended June 30, 2026.
• Exhibit: Press release announcing results furnished as Exhibit 99.1 to the 8-K.
• Signature: Report signed by Steven Coen, Chief Financial Officer.

Why It Matters

• This 8-K formally notifies investors that Ginkgo has released its quarterly earnings/financial results; the press release (Exhibit 99.1) is the place to find the specific revenue, profit/loss, and other metrics that drive stock and analyst reactions.
• Retail investors should review the attached press release and related filings on the SEC site or Ginkgo’s investor relations page for the detailed numbers and any management commentary that could affect near‑term expectations.